| Control group (n=12) | Obesity group (n=14) | P‑value |
---|---|---|---|
Patients information | |||
Age (y) | 31.00±1.86 | 31.79±1.37 | 0.227 |
BMI (kg/m2) | 20.75(20.38-21.02) | 30.70(29.25-32.33) | <0.001 |
Basal sex hormones (serum) | |||
FSH(IU/L) | 8.36±1.16 | 8.52±0.77 | 0.687 |
LH(IU/L) | 3.87±1.21 | 4.25±1.14 | 0.423 |
E2(pg/ml) | 40.50±9.06 | 34.93±8.40 | 0.117 |
P(ng/ml) | 0.68±0.25 | 0.74±0.22 | 0.549 |
TT (ng/ml) | 0.37±0.05 | 0.40±0.07 | 0.207 |
Ovarian stimulation cycles | |||
Total FSH dose (IU) | 2806.25±368.52 | 2850.00±314.09 | 0.747 |
Duration of stimulation (day) | 10.00(9.00-10.25) | 10.00(9.00-10.75) | 0.874 |
E2 on trigger day (pg/ml) | 4096.00±1022.08 | 3987.29±1065.23 | 0.794 |
LH on trigger day (IU/L) | 3.09±1.11 | 2.81±0.95 | 0.486 |
P on trigger day(ng/ml) | 1.08±0.26 | 1.02±0.23 | 0.591 |